Insurtech Bluezone has received £1.5m in funding to help grow its life insurance business and launch its first life insurance product.
The funding round was led by Insurtech Gateway and AV8 Ventures, and included investors Oxford Capital, Portfolio Ventures and the chief executive of AXA, chief transformation officer at Aegon Group and the former chairman of NHS England. The start-up insurtech plans to use the investment to expand its team and launch its first product, a Type 2 Diabetes life insurance product. Bluezone aims to "reinvent" traditional underwriting processes which are often "outdated, manual and cumbersome" and ultimately makes it difficult for individuals with chronic conditions to access insurance. ...
To continue reading this article...
Join COVER for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.
